MNK kinases facilitate c-myc IRES activity in rapamycin-treated multiple myeloma cells.

MNK kinases facilitate c-myc IRES activity in rapamycin-treated multiple myeloma cells.
复制标题

DOI:
10.1038/onc.2012.43
复制
发表时间:
2013-01-10
期刊:
影响因子:
8
通讯作者:
Lichtenstein, A.
Lichtenstein, A.
中科院分区:
医学1区
文献类型:
--
作者:
Shi, Y.;Frost, P.;Hoang, B.;Yang, Y.;Fukunaga, R.;Gera, J.;Lichtenstein, A.

文献摘要

参考文献

相似文献

When mTOR inhibitor rapalogs prevent cap-dependent translation of cell cycle proteins like cmyc, continuing tumor cell growth depends on cap-independent translation, which is mediated by internal ribosome entry sites (IRESes) located in the 5′UTR of transcripts. To investigate if rapalog-induced activation of MNK kinases played a role in such IRES activity, we studied multiple myeloma (MM) cells. Rapamycin activated MNK1 kinase activity in MM cell lines and primary specimens by a MAPK-dependent mechanism. Pharmacological inhibition of MNK activity or genetic silencing of MNK1 prevented a rapalog-induced upregulation of c-myc IRES activity. Although rapamycin, used alone, had little effect on myc protein expression, when combined with a MNK inhibitor, myc protein expression was abrogated. In contrast, there was no inhibition of myc RNA, consistent with an effect on myc translation. In a rapamycin-resistant MM cell lines as well as a resistant primary MM specimen, co-exposure to a MNK inhibitor or MNK1 knockdown significantly sensitized cells for rapamycin-induced cytoreduction. Studies in MNK-null murine embryonic fibroblasts additionally supported a role for MNK kinases in rapamycin-induced myc IRES stimulation. These results indicate that MNK kinase activity plays a critical role in the fail safe mechanism of IRES-dependent translation when mTOR is inhibited. As kinase activity also regulated sensitivity to rapamycin, the data also provide a rationale for therapeutically targeting MNK kinases for combined treatment with mTOR inhibitors.
DOI: 10.1158/1535-7163.mct-08-0254
发表时间: 2009-01
影响因子: 5.7
作者:
Frost P;Shi Y;Hoang B;Gera J;Lichtenstein A
通讯作者: Lichtenstein A
DOI: 10.1074/jbc.m309999200
发表时间: 2004-01-23
影响因子: 4.8
作者:
Gera, JF;Mellinghoff, IK;Lichtenstein, AK
通讯作者: Lichtenstein, AK
DOI: 10.1016/j.cell.2009.03.046
发表时间: 2009-05-29
期刊: Cell
影响因子: 64.5
作者:
Peterson TR;Laplante M;Thoreen CC;Sancak Y;Kang SA;Kuehl WM;Gray NS;Sabatini DM
通讯作者: Sabatini DM
DOI: 10.1128/mcb.23.16.5692-5705.2003
发表时间: 2003-08-01
影响因子: 5.3
作者:
Scheper, GC;Parra, JL;Proud, CG
通讯作者: Proud, CG
DOI: 10.1038/sj.onc.1206645
发表时间: 2003-09-11
期刊: ONCOGENE
影响因子: 8
作者:
Evans, JR;Mitchell, SA;Willis, AE
通讯作者: Willis, AE